İ | English
 

ԭҩ

м

ƺϳ

  ɳ
  ƥ̹
  ᱴ˾͡
  
  ׷
  
  
  δ¡
  δ¡
  ɳ(ˮ)
  ɳ(һˮ)
  ˾
  Dz̹
  ޶
  ׶
  
  ߻涡
  Ҷ
  Ҷ
  װ
  ˹͡
  
  
  
  ǻ
  ɳ
  
  Ī
  
  в
  
  ȥѹ
  ѹ
  Τ
  ǰ/ư
  ȸѪ
  
  
  ɳ
  
  ŵ̹
  
  Ī
  
  
  
  
  
  
  
  Ƿ/
  /
  
  ȷ«/ ߶
  
  
  
  ³
  5,6-һ-2,3--1H--2-(м)
  4-(4-)-3-ͪ (ɳм)
  (S)-(+)-N-(2,3-)ڱǰ(ɳм)
  (1S)-4,5--1-[(׻)׻](׶м)
  3-(3-ȱ)-1,3--7,8--2H-3-ӻϩ-2-ͪ (׶м)
  (2--5--3-߻ૻ)[4-[3-()]]-ͪ(δ¡м)
  (5--2--3-߻ૻ)[4-[3-()]]-ͪ(δ¡м)
  2--3-(4-)-5-߻(δ¡м)
  2--3-(4-ǻ)-5-߻(δ¡м)
  N-(3-ȱ) (δ¡м)
  4-[(4-ȱ)-2-ऻ]-1-(˹͡м)
  2-[(4-ȱ)(4-ऻ)׻] (˹͡м)
  2-[(4-ȱ)4-׻] (˹͡м)
  6-һ-5--4-ǻ(м)
  4--6-һ-5-(м)
  (2R,3S/2S,3R)-3-(4--5--6-ऻ)-2-(2,4-)-1-(1H-1,2,4--1-)-2-(м)
  (2R,3S/2S,3R)-2-(2,4-)-3-(5--4-ऻ)-1-(1H-1,2,4--1-)-2-()
  4-[(2-Ȼ)](м)
  6,11--11--[be]ӻϩ-2-()
  [3-(׻)]]l廯 (м)
  N-[4-[4-(़׻)-2-]-˳ʽ-2-ϩ-1-]ڱǰ (߻涡м)
  2--4-(-1-׻)ल(߻涡м)
  (2-߻ૼ׻ǻ)-(4-)(߻涡м)
  5,6,7,8--2-(м)
  2,3-ⱽ߻-5-(м)
  5-(2-һ)-2,3-ⱽ߻(м)
  (S)-2,2--2-(1-Լױ-3-)(м)
  2,2--2-[(3S)--3-] L-ʯ(м)
  2-(3-ȩ-4-ǻ)-4-׻-5-(Dz̹м)
  2-(3--4-춡)-4-׻-5-(Dz̹м)
  2--2-[2-[2--4-[[3-()]]]һ]-1,3-
  -7-
  2-(ȼ׻)-3-(׻)
  
  Diphenyleneiodonium Sulfate
  4--2-
  1-(2-Methylpyrimidin-5-yl)ethanamine
  3-Chloromethyl-1,2,4-oxadiazole
  5-Chloropyrazine-2-carbaldehyde
  2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester
  Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate
  Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate
  Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate
  1-(5-Methylpyrimidin-2-yl)ethanol
  7-Chloro-5-methoxy-Thieno[3,2-b]pyridine
  2-Bromo-7-chloro-thieno[3,2-b]pyridine
  5--2-
  5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one
  3-Bromo-5-methyl-1H-pyrazole
  
  ƽ
  ³ͪ
  ³ͪ
  ³ͪ
  ɳ
  άĪ
  ʯῨ͡
  ׻ɳ
  L--
  5-[(2R)-2-]-2,3--1-[3-()]-1H--7-ʯ( м)
  2-[2-(2,2,2-)]һ׻
  1--2-(2-)ͪ
  5,6,7,7a-Բ[3,2-c]-2(4H)-ͪԼױ
  5,6,7,7a--5-(׻)Բ[3,2-c]ͪ
  4-(2-һ)
  2,3,4,6--O-л-a-D-9
  лв
  4,5--1-(׶м)
  (S)-4[1-(4-ȱ)-1-(2-ऻ) ](˹͡м)
  
  (S)-(2,2-׻-1,3--4-)׻ 3-(4-ǻ)
  (S)-(+)-ˮ
  N-(2-һ)-4-
  װʶ
  2,4,5,6-İ
  6-(׻)-2,4-श
  2,3,4,6-л-D-(вм)
  8--5-(2-)-2-ǻ (м)
  (3AR,4S,7R,7AS)-rel--4,7--1H--1,3(2H)-ͪ(³ͪм)
  (3R,4R)-3-(3,4-׻-4-ऻ) (άĪм)
  (alphaS,3R,4R)-4-(3-ǻ)-3,4-׻-alpha-л-1-ऱ(άĪм)
  (R)-2-л-3-[(3R,4R)-4-(3-ǻ)-3,4-׻-1-](άĪм)
  濨Τ
  2-[(S)-(4-ȱ)(4-ऻ)׻] (2R,3R)-2,3-ǻ(˹͡м)
  (5R-cis)-ױ-4- 5-(2,4-)-5-(1H-1,2,4--1-)׻߻-3-׻
  2-[(1S,2S)-1-һ-2-]-2,4--4-[4-[4-(4-ǻ)-1-ົ]]-3H-1,2,4--3-ͪ
  ƥĪ
  
  
  ɳ̹
  
  ᰢǸ
  Ǹ
  
  Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one
  11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one
  (5-Chloro-2-phenoxyphenyl)acetic acid
  Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One
  ȼȺ׻
  ȼȺ
  3-[(3--4-׻)-2-]
  N-(4-)ʰ
  4-װ-3-
  3-(-2-)
  2-(4--1,4-ϩ-1-)-2-
  5-(1,1-׻)䱽
  2-ǻ-4-
  Ǽ׻
  Ѷǰ(SIDEA)
  ҶԼױ
  5-[(2S)-2-]-2,3--1-[3-()]-1H--7--D-(-)-ʯ
  5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE
  (R)--3-
  ethyl 4-(4-hydroxypiperidin-1-yl) butanoate
  (S)-(4-ȱ)(-2-)״
  ethyl 4-(4-bromoypiperidin-1-yl)butanoate
  1--3-
  ɳԼױһˮ
  ɳBASE
  ɳм1
  ɳм2
  ɳм3
  N-[3--4-[(׻)ʻ]]-2-׻-
  N-[3--4-[(׻)ʻ]]-2-׻-
  4--2-(׻)
  ³
  1--4-
  THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA
  esinurad
  (R)-3--1-
  1533519-85-5
  ˹
  ˹
  4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
  ᰢ氷
  
  MK-4305
  б˾
  ±
Ʒ:(2-߻ૼ׻ǻ)-(4-)(߻涡м) 
Cas No.:123855-55-0 
:99% 
ʽ:C13H11NO6S 
:309.29 
ṹʽ: 
     
2011ҽҩ޹˾Ȩ  |  ICP09110018  |  ַк·4AԺ3¥323
绰 010-88755821  |   棺 010-58043698  |   ϵˣ
䣺Contact@EagleSkyPharmatech.com  |  marketing@EagleSkyPharmatech.com ֧֣Ļ